CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-23 | PACE GARY W Director | Purchase | +5,000 | $10.20 | $51K | 459,811 |
| 2021-03-23 | PACE GARY W Director | Purchase | +2,500 | $10.21 | $26K | 462,311 |
| 2021-03-23 | PACE GARY W Director | Purchase | +2,500 | $10.31 | $26K | 464,811 |
| 2021-03-23 | JACOB GARY S Director | Purchase | +1,900 | $10.42 | $20K | 21,452 |
| 2021-03-23 | JACOB GARY S Director | Purchase | +470 | $10.40 | $5K | 21,922 |
| 2021-03-23 | Kelemen Vicki Exec. VP and COO | Purchase | +960 | $10.31 | $10K | 6,053 |
| 2021-03-23 | Erlander Mark Chief Executive Officer | Purchase | +965 | $10.34 | $10K | 14,481 |
| 2021-03-22 | BRANCACCIO JOHN P Director | Purchase | +3,000 | $10.95 | $33K | 12,260 |
| 2021-03-19 | Armitage James O Director | Purchase | +4,000 | $10.82 | $43K | 14,490 |
| 2021-03-18 | PACE GARY W Director | Purchase | +1,000 | $10.58 | $11K | 452,811 |
| 2021-03-18 | PACE GARY W Director | Purchase | +2,000 | $10.54 | $21K | 454,811 |
| 2021-03-04 | PACE GARY W Director | Purchase | +1,500 | $9.27 | $14K | 451,811 |
| 2021-01-02 | Kelemen Vicki Exec. VP and COO | Option exercise | +70 | 5,124 | ||
| 2021-01-02 | Kelemen Vicki Exec. VP and COO | Shares withheld for taxes | −31 | 5,093 | ||
| 2021-01-02 | Kelemen Vicki Exec. VP and COO | Option exercise · Restricted Stock Units | −70 | 0 | ||
| 2021-01-02 | Erlander Mark Chief Executive Officer | Option exercise | +260 | 13,629 | ||
| 2021-01-02 | Erlander Mark Chief Executive Officer | Shares withheld for taxes | −113 | 13,516 | ||
| 2021-01-02 | Erlander Mark Chief Executive Officer | Option exercise · Restricted Stock Units | −260 | 0 | ||
| 2020-11-23 | Kelemen Vicki Exec. VP and COO | Option exercise | +35,321 | $2.48 | $88K | 40,375 |
| 2020-11-23 | Kelemen Vicki Exec. VP and COO | Sale | −35,321 | $18.60 | $657K | 5,054 |
Page 7 of 8 · 144 trades